JiscMail Logo
Email discussion lists for the UK Education and Research communities

Help for ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN Archives

ACB-CLIN-CHEM-GEN Archives


ACB-CLIN-CHEM-GEN@JISCMAIL.AC.UK


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN Home

ACB-CLIN-CHEM-GEN  1999

ACB-CLIN-CHEM-GEN 1999

Options

Subscribe or Unsubscribe

Subscribe or Unsubscribe

Log In

Log In

Get Password

Get Password

Subject:

Faecal Occult Blood hits the NHS

From:

"Jonathan Kay" <[log in to unmask]>

Reply-To:

Jonathan Kay

Date:

3 Mar 1999 20:28:31 +0000

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (131 lines)


DEPARTMENT OF HEALTH
1999/0116                                      Tuesday 2nd March 1999
 
    TESSA JOWELL ANNOUNCES COLORECTAL CANCER SCREENING PILOT SITES
 
The English site for the pilot study to evaluate a screening 
programme for colorectal cancer was announced today by Tessa Jowell, 
Minister for Public Health.
 
Ms Jowell said:
 
"I am very pleased to announce that the pilot site for colorectal 
cancer screening in England will be in Coventry and Warwickshire. My 
colleague Sam Galbraith, Scottish Health Minister, also announced 
today that the Scottish pilot site will be in Tayside, Grampian and 
Fife.  This is an exciting and groundbreaking scheme and will be the 
first programme of its kind in Europe.
 
" About 20,000 people a year die from colorectal cancer and many of 
them could have been saved if their cancer had been found earlier.  
Many people suffer in silence, too embarrassed to tell their partners
or even their doctors.  But, if it is caught early, colorectal cancer
is one of the most curable of all cancers.  I therefore urge the 
people in Coventry and Warwickshire to take part in the pilots when 
they are invited.  Their support could make a big difference in how 
effectively we tackle this disease in the future.
 
"Colorectal cancer is the second most common cancer in this country. 
We have already made an extra #10 million available for faster access
to diagnosis and treatment of colorectal cancer.  Screening may be 
another way to help improve people's chance of surviving this 
terrible disease."
 
David Loughton, the Chief Executive of the Walsgrave Hospitals NHS 
Trust in Coventry, which provides the cancer centre for the project, 
said:
 
"I am delighted we have been chosen as the pilot site. Staff have 
been working together across three Trusts and two Health Authorities 
to make this a success.  Our partnership and ability to work well 
together have helped us secure this project.
 
"We will be asking thousands of people across the area to help with 
this research - it could save your life and provide information in 
the fight to save others."
 
The practical knowledge gained from the pilots will be crucial to 
informing the National Screening Committee's consideration of the 
feasibility of a national approach.  The projects will cost about #5 
million and run for over two years.
 
NOTES FOR EDITORS
 
1. The UK National Screening Committee (NSC) includes the all UK 
CMOs, professionals & experts, members from public health, external 
research organisations, media and consumer representative 
organisations. It considers clinical evidence on population screening
from research programmes and makes recommendations to Health 
Ministers about:
 
 The case for implementing new population screening programmes not 
presently purchased by the NHS within each of the countries in the UK
Screening technologies of proven effectiveness but  which require 
controlled and well-managed introduction.  The case for continuing, 
modifying or withdrawing existing population screening  programmes.  
In particular, programmes  inadequately evaluated or of doubtful 
effectiveness, quality, or value.
 
2. Faecal Occult Blood Test kit will be sent directly to homes with 
instructions for use, together with an background information about 
the test and follow up. A small sample of faeces is given and can 
then be sent to the laboratory for testing. People can, of course, go
to their GP practice for help and advice, if they wish. At the 
laboratory test is then undertaken for blood in the faeces. It is not
a definitive test for cancer. Positive tests require a speedy 
follow-up: some people might be asked to submit a second sample after
following a restricted diet for a few days, to ensure that the test 
result was accurate; others might be invited for a follow-up 
diagnostic test - a colonoscopy or a double contrast barium enema 
together with a flexible sigmoidoscopy. This will be able tell if 
pre-cancerous cells or polyps are present and what treatment might be
required.
 
3. The chosen site at Coventry and Warwickshire comprises to two 
Health Authorities: Coventry and Warwickshire; and three NHS Trusts: 
Walsgrave Hospitals Trust, where the cancer centre is based, George 
Elliot Trust and South Warwickshire General Hospitals Trust.
 
4.  Mrs Jowell accepted advice from an advisory panel of leading 
specialist practitioners from NHS and patient representative groups, 
the Crocus Trust and Colon Cancer Concern. The panel considered a 
shortlist of five sites and judged that Coventry & Warwickshire, and 
Tayside were best placed to provide a pilot service which would 
address the practical challenges of establishing a new NHS screening 
programme.  Work is starting now to prepare local services for 
delivering this two year local programme.
 
5. It is intended that the screening centre in the pilot site will 
offer a freephone advice service similar to that being developed 
through NHS Direct. Callers will receive clear advice about the 
service being offered and whether they might take part. Although they
won't receive an invitation those over 69 can contact the advice line
to receive a testing kit if they wish to participate in the pilot.  
The pilots will be developed with a strong commitment to involving 
the local community and raising of awareness of the disease more 
broadly.
 
6.  A single evaluation project will review the results and report to
the National Screening Committee in 2001/2.
 
7.  There are over 30,000 new cases a year of this cancer. Ninety 
three percent of deaths occur in people over 55, incidence increases 
with age and there is a lifetime risk of 1 in 25.
 
                                [ENDS]
 
 
 
 
 
 
 
# = pounds sterling





%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

Top of Message | Previous Page | Permalink

JiscMail Tools


RSS Feeds and Sharing


Advanced Options


Archives

May 2024
April 2024
March 2024
February 2024
January 2024
December 2023
November 2023
October 2023
September 2023
August 2023
July 2023
June 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
September 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
August 2021
July 2021
June 2021
May 2021
April 2021
March 2021
February 2021
January 2021
December 2020
November 2020
October 2020
September 2020
August 2020
July 2020
June 2020
May 2020
April 2020
March 2020
February 2020
January 2020
December 2019
November 2019
October 2019
September 2019
August 2019
July 2019
June 2019
May 2019
April 2019
March 2019
February 2019
January 2019
December 2018
November 2018
October 2018
September 2018
August 2018
July 2018
June 2018
May 2018
April 2018
March 2018
February 2018
January 2018
December 2017
November 2017
October 2017
September 2017
August 2017
July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
April 2016
March 2016
February 2016
January 2016
December 2015
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
2006
2005
2004
2003
2002
2001
2000
1999
1998


JiscMail is a Jisc service.

View our service policies at https://www.jiscmail.ac.uk/policyandsecurity/ and Jisc's privacy policy at https://www.jisc.ac.uk/website/privacy-notice

For help and support help@jisc.ac.uk

Secured by F-Secure Anti-Virus CataList Email List Search Powered by the LISTSERV Email List Manager